Rocco Mazzaferro,Marco Ferrara,Riccardo Giovannini,Iain Lingard,Klaus Rudolf
申请号:
US15526361
公开号:
US10071974B2
申请日:
2015.11.12
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention relates to morpholine and 1,4-oxazepane amide derivatives of general formula (I), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture of the compounds according to the invention.